A dedicated clinical school in rare immune mediated liver diseases including PBC, AIH, PSC, IgG4 related disease, liver disease in patients with primary immunodeficiency and those treated with immune checkpoint inhibitors. The course will follow an inverted classroom model and will rely on local expertise from the Sheila Sherlock Liver Centre at the Royal Free Hospital and the UCL Institute for Liver and Digestive Health, London, UK in all aspects. Over two days, attendees will have the opportunity to learn about the state of the art management and the approach to clinical controversies in this challenging area of hepatological practice. Delegates will then undertake clinical case-based group sessions, facilitated by local experts and feedback key learning points to their colleagues. These feedback sessions will then form the basis of interactive panel discussion amongst delegates and faculty.
Topics: Immune mediated and cholestatic diseases